Author:
Ghabri Salah,Lam Laurent,Bocquet François,Spath Hans-Martin
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference78 articles.
1. Canadian Agency for Drugs and Technologies in Health. Drugs for the management of rheumatoid arthritis: clinical evaluation. Ottawa: CADTH; 2018. https://www.cadth.ca/sites/default/files/pdf/HT0010_RA_Report.pdf. Accessed July 25, 2019.
2. Gaujoux-Viala C, Gossec L, Cantagrel A, French Society for Rheumatology, et al. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. Joint Bone Spine. 2014;81(4):287–97.
3. Simpson EL, Ren S, Hock ES, et al. Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. Int J Technol Assess Health Care. 2019;35(1):36–44.
4. Daien C, Hua C, Gaujoux-Viala C, et al. Update of French Society for Rheumatology recommendations for managing rheumatoid arthritis. Joint Bone Spine. 2019;86(2):135–50.
5. Zheng Y, Pan F, Sorensen S. Modeling treatment sequences in pharmacoeconomic models. Pharmacoeconomics. 2017;35(1):15–24.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献